![]() AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine. | ![]() Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. | ![]() Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry. | ![]() Mustang Bio Mustang Bio is a clinical-stage biopharmaceutical company that specializes in the development of cell and gene therapies. | |
Founding Date | Founding Date 1999 | Founding Date 1995 | Founding Date 2014 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more | Locations Cambridge, US HQ | Locations Worcester, US HQ |
Employees | Employees 5562% decrease | Employees 20216% increase | Employees 40323% decrease | Employees 693% decrease |
Valuation ($) | Valuation ($) 78.3 m | Valuation ($) 737.4 m | Valuation ($) 1.7 b | Valuation ($) 11.2 m |
Financial | ||||
Revenue (est.) | Revenue (est.) ¥874.1m (FY, 2025) | Revenue (est.) $49.8m (FY, 2025) | Revenue (est.) $67.7m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥499.9m (FY, 2025) | Cost of goods $274k (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥374.2m (FY, 2025) | Gross profit $49.5m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income (¥5.1b) (FY, 2025) | Net income ($50.3m) (FY, 2025) | Net income ($412.7m) (FY, 2025) | Net income ($1.9m) (FY, 2025) |

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
View company
Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.
View company
Mustang Bio is a clinical-stage biopharmaceutical company that specializes in the development of cell and gene therapies.
View company